Toggle navigation
Home
Search
Services
Blog
Contact
About
Generation and Use of Recombinant Delta Lactoferrin
Siebert, Paul D.
Clontech Laboratories, Inc., Palo Alto, CA, United States
Search 7 grants from Paul Siebert
Search grants from Clontech Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
University of Pennsylvania
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Engineered Cardiac Tissue with Biomimetic Architecture and Vasculature
Rural Disparities in Pediatric Obesity: The iAmHealthy Intervention
Genetic Architecture of the Mammalian (Canid) Skeleton
Neonate Hearing Simulator
Breath Hold 3D Mra of the Coronary Arteries
Recently added grants:
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
Large-scale screen with a novel assay against RNA editing to identify anti-trypanosomal agents
Impact of Cumulative Exposure to Respiratory Viruses after Allogeneic Hematopoietic Cell Transplantation
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
Regulation of the Immune Response to Plasmodium by IL-10 Producing Natural Killer Cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA075066-01
Application #
2377235
Study Section
Special Emphasis Panel (ZRG3-SSS-2 (01))
Project Start
1997-09-30
Project End
1998-09-29
Budget Start
1997-09-30
Budget End
1998-09-29
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Clontech Laboratories, Inc.
Department
Type
DUNS #
City
Palo Alto
State
CA
Country
United States
Zip Code
94303
Comments
Be the first to comment on Paul Siebert's grant